Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Increased Frequency of Heterozygous Alpha-1 Antitrypsin Deficiency in Liver Explants from Non-Alcoholic Steatohepatitis Patients.

Cheeney G, Pac LJ, Gopal P, Landis CS, Konnick EQ, Swanson PE, Greene DN, Lockwood CM, Westerhoff M.

Liver Transpl. 2019 Oct 9. doi: 10.1002/lt.25652. [Epub ahead of print]

PMID:
31597010
2.

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP).

Cheung CC, Barnes P, Bigras G, Boerner S, Butany J, Calabrese F, Couture C, Deschenes J, El-Zimaity H, Fischer G, Fiset PO, Garratt J, Geldenhuys L, Gilks CB, Ilie M, Ionescu D, Lim HJ, Manning L, Mansoor A, Riddell R, Ross C, Roy-Chowdhuri S, Spatz A, Swanson PE, Tron VA, Tsao MS, Wang H, Xu Z, Torlakovic EE; Canadian Association of Pathologists-Association Canadienne Des Pathologistes’ National Standards Committee for High Complexity Testing (CAP-ACP NSCHCT).

Appl Immunohistochem Mol Morphol. 2019 Nov/Dec;27(10):699-714. doi: 10.1097/PAI.0000000000000800.

PMID:
31584451
3.

Utility of glutamine synthetase immunohistochemistry in identifying features of regressed cirrhosis.

Hadi R, Shin K, Reder N, Alpert L, Koch L, Choi WT, Swanson PE, Hart J, Westerhoff M.

Mod Pathol. 2019 Aug 7. doi: 10.1038/s41379-019-0346-1. [Epub ahead of print]

PMID:
31391527
4.

"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy.

Torlakovic E, Lim HJ, Adam J, Barnes P, Bigras G, Chan AWH, Cheung CC, Chung JH, Couture C, Fiset PO, Fujimoto D, Han G, Hirsch FR, Ilie M, Ionescu D, Li C, Munari E, Okuda K, Ratcliffe MJ, Rimm DL, Ross C, Røge R, Scheel AH, Soo RA, Swanson PE, Tretiakova M, To KF, Vainer GW, Wang H, Xu Z, Zielinski D, Tsao MS.

Mod Pathol. 2019 Aug 5. doi: 10.1038/s41379-019-0327-4. [Epub ahead of print] Review.

PMID:
31383961
5.

Predictive Markers Require Thorough Analytic Validation.

Troxell ML, Fulton RS, Swanson PE, Bellizzi AM, Fitzgibbons PL, Ambaye AB, Haas TS, Goldsmith JD, Loykasek PA, Miller DV, O'Malley D, Qiu J, Salama ME, Schaberg KB, Schwartz RA, Shia J, Summers TA Jr, Wu Y.

Arch Pathol Lab Med. 2019 Aug;143(8):907-909. doi: 10.5858/arpa.2019-0112-LE. No abstract available.

PMID:
31339757
6.

Protein Losing Enteropathy due to Gut Plasmacytoma Polyposis.

Jacobs JD, Swanson PE, Brentnall T.

Am J Gastroenterol. 2019 Jun 12. doi: 10.14309/ajg.0000000000000291. [Epub ahead of print] No abstract available.

PMID:
31205137
7.

An Unusual Cause of Abdominal Pain.

Baxi AC, Swanson PE, Tomizawa Y.

Gastroenterology. 2019 Apr 11. pii: S0016-5085(19)35688-4. doi: 10.1053/j.gastro.2019.04.008. [Epub ahead of print] No abstract available.

PMID:
30981789
8.

Validation of a Congestive Hepatic Fibrosis Scoring System.

Bosch DE, Koro K, Richards E, Hoch BL, Jalikis F, Koch LK, Swanson PE, Truong CD, Liou I, Yu L, Bhattacharya R, Yeh MM.

Am J Surg Pathol. 2019 Jun;43(6):766-772. doi: 10.1097/PAS.0000000000001250.

PMID:
30950843
9.

Validation and Proficiency Testing of Biomarker Immunohistochemistry: Diagnostic Accuracy "Fit for Purpose" in a 3D World.

Swanson PE.

Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):247-250. doi: 10.1097/PAI.0000000000000746. No abstract available.

PMID:
30720467
10.

Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast Cancer.

Kilgore MR, Bosch DE, Adamson KH, Swanson PE, Dintzis SM, Rendi MH.

Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):637-643. doi: 10.1097/PAI.0000000000000707.

PMID:
30358609
11.

Gallbladder carcinoma and epithelial dysplasia: Appropriate sampling for histopathology.

Bosch DE, Yeh MM, Schmidt RA, Swanson PE, Truong CD.

Ann Diagn Pathol. 2018 Dec;37:7-11. doi: 10.1016/j.anndiagpath.2018.08.003. Epub 2018 Sep 5.

PMID:
30216818
12.

Small Biopsies Misclassify up to 35% of PD-L1 Assessments in Advanced Lung Non-Small Cell Lung Carcinomas.

Bigras G, Mairs S, Swanson PE, Morel D, Lai R, Izevbaye I.

Appl Immunohistochem Mol Morphol. 2018 Nov/Dec;26(10):701-708. doi: 10.1097/PAI.0000000000000698.

PMID:
30095468
13.

Pillars Article: IFNγ and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. Nature. 2001. 410: 1107-1111.

Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD.

J Immunol. 2018 Aug 1;201(3):827-831. No abstract available.

14.

Uneven Staining in Automated Immunohistochemistry: Cold and Hot Zones and Implications for Immunohistochemical Analysis of Biopsy Specimens.

Cheung CC, Swanson PE, Nielsen S, Vyberg M, Torlakovic EE.

Appl Immunohistochem Mol Morphol. 2018 May/Jun;26(5):299-304. doi: 10.1097/PAI.0000000000000656.

PMID:
29734239
15.

Increased expression of senescence-associated cell cycle regulators in the progression of biliary atresia: an immunohistochemical study.

Sasaki M, Kuo FY, Huang CC, Swanson PE, Chen CL, Chuang JH, Yeh MM.

Histopathology. 2018 Jun;72(7):1164-1171. doi: 10.1111/his.13476. Epub 2018 Mar 9.

PMID:
29392752
16.

Influence of autophagy on acute kidney injury in a murine cecal ligation and puncture sepsis model.

Sunahara S, Watanabe E, Hatano M, Swanson PE, Oami T, Fujimura L, Teratake Y, Shimazui T, Lee C, Oda S.

Sci Rep. 2018 Jan 18;8(1):1050. doi: 10.1038/s41598-018-19350-w.

17.

Blocking Liver Autophagy Accelerates Apoptosis and Mitochondrial Injury in Hepatocytes and Reduces Time to Mortality in a Murine Sepsis Model.

Oami T, Watanabe E, Hatano M, Teratake Y, Fujimura L, Sakamoto A, Ito C, Toshimori K, Swanson PE, Oda S.

Shock. 2018 Oct;50(4):427-434. doi: 10.1097/SHK.0000000000001040.

PMID:
29076973
18.

Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.

Murphy CE, McCormick KA, Shankaran V, Reddi DM, Swanson PE, Upton MP, Papanicolau-Sengos A, Khor S, Westerhoff M.

Pancreas. 2017 Nov/Dec;46(10):1359-1365. doi: 10.1097/MPA.0000000000000923.

PMID:
29040195
19.

Radiologically Undetected Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation: An Immunohistochemical Correlation With LI-RADS Score.

Xiong W, Cheeney G, Kim S, Kolesnikova V, Henninger B, Alexander J, Swanson PE, Upton MP, Truong CD, Yeh MM.

Am J Surg Pathol. 2017 Nov;41(11):1466-1472. doi: 10.1097/PAS.0000000000000955.

PMID:
28914714
20.

Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ.

Bosch DE, Kilgore MR, Schmidt RA, Swanson PE, Rendi MH, Chang OH.

Appl Immunohistochem Mol Morphol. 2017 Sep;25(8):543-547. doi: 10.1097/PAI.0000000000000555.

PMID:
28885232
21.

Massive Gastric Juvenile Polyposis: A Clinicopathologic Study Using SMAD4 Immunohistochemistry.

Lawless ME, Toweill DL, Jewell KD, Jain D, Lamps L, Krasinskas AM, Swanson PE, Upton MP, Yeh MM.

Am J Clin Pathol. 2017 Apr 1;147(4):390. doi: 10.1093/ajcp/aqx015.

PMID:
28340255
22.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories.

Torlakovic EE, Cheung CC, D'Arrigo C, Dietel M, Francis GD, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Vyberg M, Zhou X, Taylor CR; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path).

Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):151-159. doi: 10.1097/PAI.0000000000000470.

PMID:
28187030
23.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.

Torlakovic EE, Cheung CC, D'Arrigo C, Dietel M, Francis GD, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Vyberg M, Zhou X, Taylor CR; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path).

Appl Immunohistochem Mol Morphol. 2017 Feb;25(2):79-85. doi: 10.1097/PAI.0000000000000444. Review.

PMID:
28182587
24.

Cutaneous Involvement by Nasal Mucoepidermoid Carcinoma: The Tip of the Iceberg Phenomenon.

Zhao G, Chang O, Streidl J, Bhrany A, Garton K, McCalmont TH, Swanson PE, Argenyi Z, Shinohara MM.

J Cutan Pathol. 2017 Feb;44(2):113-117. doi: 10.1111/cup.12817. No abstract available.

PMID:
28102567
25.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry.

Cheung CC, D'Arrigo C, Dietel M, Francis GD, Fulton R, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Taylor CR, Vyberg M, Zhou X, Torlakovic EE; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path).

Appl Immunohistochem Mol Morphol. 2017 Apr;25(4):227-230. doi: 10.1097/PAI.0000000000000469.

PMID:
27941560
26.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers.

Cheung CC, D'Arrigo C, Dietel M, Francis GD, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Taylor CR, Vyberg M, Zhou X, Torlakovic EE; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path).

Appl Immunohistochem Mol Morphol. 2017 Jan;25(1):4-11.

PMID:
27922482
27.

Autophagy and its current relevance to the diagnosis and clinical management of esophageal diseases.

Langer R, Streutker CJ, Swanson PE.

Ann N Y Acad Sci. 2016 Oct;1381(1):113-121. doi: 10.1111/nyas.13190. Epub 2016 Aug 15. Review.

PMID:
27526024
28.

Rare tumors of esophageal squamous mucosa.

Tripathi M, Swanson PE.

Ann N Y Acad Sci. 2016 Oct;1381(1):122-132. doi: 10.1111/nyas.13108. Epub 2016 Jun 16. Review.

PMID:
27310830
29.

Cytomegalovirus (CMV) in gastrointestinal mucosal biopsies: should a pathologist perform CMV immunohistochemistry if the clinician requests it?

Juric-Sekhar G, Upton MP, Swanson PE, Westerhoff M.

Hum Pathol. 2017 Feb;60:11-15. doi: 10.1016/j.humpath.2016.09.009. Epub 2016 Sep 22.

PMID:
27666768
30.

Diagnostic immunohistochemistry through Rosai-coloured glasses.

Swanson PE.

Semin Diagn Pathol. 2016 Sep;33(5):343-56. doi: 10.1053/j.semdp.2016.07.001. Epub 2016 Jul 19.

PMID:
27514237
31.

Glutamine Synthetase Immunoreactivity in Peritumoral Hyperplasia in Liver:  Case Report of a Metastatic Paraganglioma With Focal Nodular Hyperplasia-Like Changes and Review of an Additional 54 Liver Masses.

Bryant BH, Zenali MJ, Swanson PE, Upton MP, Yeh MM, Cuevas C, Park JO, Westerhoff M.

Am J Clin Pathol. 2016 Aug;146(2):254-61. doi: 10.1093/ajcp/aqw056. Epub 2016 May 31. Review.

PMID:
27247379
32.

New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma.

Bigras G, Dong WF, Canil S, Lai R, Morel D, Swanson PE, Izevbaye I.

Appl Immunohistochem Mol Morphol. 2018 Jan;26(1):54-63. doi: 10.1097/PAI.0000000000000367.

33.

Using IHC to Predict Local Recurrence/Progression of DCIS: A Search for a More Cost-effective Solution.

Kilgore MR, Chang OH, Swanson PE, Schmidt RA, Garcia RL, Rendi MH.

Breast J. 2016 Mar-Apr;22(2):247-8. doi: 10.1111/tbj.12561. Epub 2015 Dec 23. No abstract available.

PMID:
26696338
34.

Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.

Lee S, Piskorz AM, Le Page C, Mes Masson AM, Provencher D, Huntsman D, Chen W, Swanson PE, Gilks CB, Köbel M.

Int J Gynecol Pathol. 2016 May;35(3):209-21. doi: 10.1097/PGP.0000000000000251.

PMID:
26598982
35.

Principles of Analytic Validation of Clinical Immunohistochemistry Assays.

Goldsmith JD, Fitzgibbons PL, Swanson PE.

Adv Anat Pathol. 2015 Nov;22(6):384-7. doi: 10.1097/PAP.0000000000000094. Review.

PMID:
26452213
36.

Lymphangiomatous Lesions of the Gastrointestinal Tract: A Clinicopathologic Study and Comparison Between Adults and Children.

Lawless ME, Lloyd KA, Swanson PE, Upton MP, Yeh MM.

Am J Clin Pathol. 2015 Oct;144(4):563-9. doi: 10.1309/AJCPO8TW6EMAJSRP.

PMID:
26386077
37.

Association Between Phosphorylated Histone H3 and Oncotype DX Recurrence Scores in Breast Cancer.

Lee LH, Swanson PE, Tang PA, Bigras G, Yang H.

Appl Immunohistochem Mol Morphol. 2017 Jan;25(1):25-31.

38.

Immunohistochemical characterization of the regenerative compartment in biliary atresia: a comparison between Kasai procedure and transplant cases.

Kuo FY, Huang CC, Chen CL, Chuang JH, Riehle K, Swanson PE, Yeh MM.

Hum Pathol. 2015 Nov;46(11):1633-9. doi: 10.1016/j.humpath.2015.07.003. Epub 2015 Jul 15.

PMID:
26297252
39.

The outcomes of "atypical" and "suspicious" bile duct brushings in the identification of pancreaticobiliary tumors: Follow-up analysis of surgical resection specimens.

Choi WT, Swanson PE, Grieco VS, Wang D, Westerhoff M.

Diagn Cytopathol. 2015 Nov;43(11):885-91. doi: 10.1002/dc.23323. Epub 2015 Jul 27.

PMID:
26221777
40.

Is "Polysomy" in Breast Carcinoma the "New Equivocal" in HER2 Testing?

Swanson PE, Yang H.

Am J Clin Pathol. 2015 Aug;144(2):181-4. doi: 10.1309/AJCP95QBHQWGGNJP. No abstract available.

PMID:
26185303
41.

The Effects of Local Warming on Surgical Site Infection.

Whitney JD, Dellinger EP, Weber J, Swenson RE, Kent CD, Swanson PE, Harmon K, Perrin M.

Surg Infect (Larchmt). 2015 Oct;16(5):595-603. doi: 10.1089/sur.2013.096. Epub 2015 Jun 30.

42.

Immunohistochemistry as a surrogate for molecular testing: a review.

Swanson PE.

Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):81-96. doi: 10.1097/PAI.0000000000000181. Review.

PMID:
25675083
43.

Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.

Torlakovic EE, Nielsen S, Francis G, Garratt J, Gilks B, Goldsmith JD, Hornick JL, Hyjek E, Ibrahim M, Miller K, Petcu E, Swanson PE, Zhou X, Taylor CR, Vyberg M.

Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):1-18. doi: 10.1097/PAI.0000000000000163. Review.

PMID:
25474126
44.

Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistry.

Cheung CC, Banerjee D, Barnes PJ, Berendt RC, Butany J, Canil S, Clarke BA, El-Zimaity H, Garratt J, Geldenhuys L, Gilks CB, Manning L, Mengel M, Perez-Ordonez B, Pilavdzic D, Riddell R, Swanson PE, Torlakovic EE.

Am J Clin Pathol. 2014 Nov;142(5):629-33. doi: 10.1309/AJCP77GXYVEQXMXT.

PMID:
25319977
45.

Therapeutic approaches to gastroesophageal junction adenocarcinomas.

Blom RL, Bogush T, Brücher BL, Chang AC, Davydov M, Dudko E, Leong T, Polotsky B, Swanson PE, van Rossum PS, Ruurda JP, Sagaert X, Tjulandin S, Schraepen MC, Sosef MN, van Hillegersberg R.

Ann N Y Acad Sci. 2014 Sep;1325:197-210. doi: 10.1111/nyas.12532.

46.

Coping with esophageal cancer approaches worldwide.

Cotton RG, Langer R, Leong T, Martinek J, Sewram V, Smithers M, Swanson PE, Qiao YL, Udagawa H, Ueno M, Wang M, Wei WQ, White RE.

Ann N Y Acad Sci. 2014 Sep;1325:138-58. doi: 10.1111/nyas.12522.

PMID:
25266022
47.

Progression of esophageal dysplasia to cancer.

Appelman HD, Matejcic M, Parker MI, Riddell RH, Salemme M, Swanson PE, Villanacci V.

Ann N Y Acad Sci. 2014 Sep;1325:96-107. doi: 10.1111/nyas.12523.

48.

Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity.

Dai DF, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM.

Mod Pathol. 2014 Dec;27(12):1552-8. doi: 10.1038/modpathol.2014.79. Epub 2014 Jun 13.

49.

Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.

Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu EB, Swanson PE, Taylor CR, Vyberg M; International Ad Hoc Expert Panel.

Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):241-52. doi: 10.1097/PAI.0000000000000069.

50.

Proliferative, reparative, and reactive benign bone lesions that may be confused diagnostically with true osseous neoplasms.

Wick MR, McDermott MB, Swanson PE.

Semin Diagn Pathol. 2014 Jan;31(1):66-88. doi: 10.1053/j.semdp.2013.12.002. Epub 2013 Dec 25. Review.

PMID:
24680184

Supplemental Content

Loading ...
Support Center